Alzheimer's disease is an extremely popular cause of dementia which leads to memory loss, problem-solving and other thinking abilities that are severe enough to interfere with daily life. Detection of Alzheimer’s at a prior stage is crucial as it can prevent significant damage to the patient’s brain. In this paper, a method to detect Alzheimer’s Disease from Brain MRI images is proposed. The proposed approach extracts shape features and texture of the Hippocampus region from the MRI scans and a Neural Network is used as a Multi-Class Classifier for detection of AD. The proposed approach is implemented and it gives better accuracy as compared to conventional approaches. In this paper, Convolutional Neural Network is the Neural Network approach used for the detection of AD at a prodromal stage.
Alzheimer’s disease is a condition that leads to, progressive neurological brain disorder and destroys cells of the brain thereby causing an individual to lose their ability to continue daily activities and also hampers their mentality. Diagnostic symptoms are experienced by patients usually at later stages after irreversible neural damage occurs. Detection of AD is challenging because sometimes the signs that distinguish AD MRI data, can be found in MRI data of normal healthy brains of older people. Even though this disease is not completely curable, earlier detection can aid in promising treatment and prevent permanent damage to brain tissues. Age and genetics are the greatest risk factors for this disease. This paper presents the latest reports on AD detection based on different types of Neural Network Architectures.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.